相似文献
1
Advancing pharmacometrics and systems pharmacology.
Clin Pharmacol Ther. 2012 Nov;92(5):535-7. doi: 10.1038/clpt.2012.151.
2
ASCPT Task Force for advancing pharmacometrics and integration into drug development.
Clin Pharmacol Ther. 2010 Aug;88(2):158-61. doi: 10.1038/clpt.2010.141.
3
Clinical Pharmacology & Therapeutics: the next five years.
Clin Pharmacol Ther. 2015 Jan;97(1):2-6. doi: 10.1002/cpt.22. Epub 2014 Dec 5.
4
Pharmacometrics and Systems Pharmacology 2030.
Clin Pharmacol Ther. 2020 Jan;107(1):76-78. doi: 10.1002/cpt.1683. Epub 2019 Nov 23.
5
CPT: Pharmacometrics and Systems Pharmacology.
CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1(9):e8. doi: 10.1038/psp.2012.8.
6
Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics.
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):3. doi: 10.1007/s10928-011-9237-x.
7
Clinical Pharmacology & Therapeutics: Past, Present, and Future.
Clin Pharmacol Ther. 2017 Mar;101(3):300-303. doi: 10.1002/cpt.592.
8
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision.
Clin Pharmacol Ther. 2023 Sep;114(3):507-510. doi: 10.1002/cpt.2955. Epub 2023 Jun 11.
9
The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Eur J Pharm Sci. 2023 Mar 1;182:106380. doi: 10.1016/j.ejps.2023.106380. Epub 2023 Jan 10.
10
Pharmacology 2.0.
Br J Clin Pharmacol. 2013 Nov;76(5):625-9. doi: 10.1111/bcp.12088.
引用本文的文献
1
Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.
Front Pharmacol. 2017 Mar 27;8:155. doi: 10.3389/fphar.2017.00155. eCollection 2017.
2
Companion diagnostics at the intersection of personalized medicine and healthcare delivery.
Biomark Med. 2015;9(1):1-3. doi: 10.2217/bmm.14.99.
3
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.
Front Pharmacol. 2014 Oct 31;5:231. doi: 10.3389/fphar.2014.00231. eCollection 2014.
4
Systems approaches evolve clinical pharmacology.
CPT Pharmacometrics Syst Pharmacol. 2013 Aug 21;2(8):e68. doi: 10.1038/psp.2013.48.
本文引用的文献
1
CPT: Pharmacometrics and Systems Pharmacology.
CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1(9):e8. doi: 10.1038/psp.2012.8.
2
Models of physiology and physiologically based models in clinical pharmacology.
Clin Pharmacol Ther. 2012 Jul;92(1):3-6. doi: 10.1038/clpt.2012.67.
3
Improving productivity with model-based drug development: an enterprise perspective.
Clin Pharmacol Ther. 2010 Aug;88(2):263-8. doi: 10.1038/clpt.2010.117. Epub 2010 Jun 30.
4
The challenge of complexity.
Clin Pharmacol Ther. 2010 Jul;88(1):13-5. doi: 10.1038/clpt.2009.267.
5
Systems clinical pharmacology.
Clin Pharmacol Ther. 2010 Jul;88(1):3-6. doi: 10.1038/clpt.2010.88.
6
Systems biology: an approach.
Clin Pharmacol Ther. 2010 Jul;88(1):25-33. doi: 10.1038/clpt.2010.92. Epub 2010 Jun 9.
7
Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
Clin Pharmacol Ther. 2010 Jul;88(1):135-7. doi: 10.1038/clpt.2010.81. Epub 2010 Jun 9.
8
Multiscale modeling in drug discovery and development: future opportunities and present challenges.
Clin Pharmacol Ther. 2010 Jul;88(1):126-9. doi: 10.1038/clpt.2010.87. Epub 2010 Jun 2.
9
The systems biology approach to drug development: application to toxicity assessment of cardiac drugs.
Clin Pharmacol Ther. 2010 Jul;88(1):130-4. doi: 10.1038/clpt.2010.95. Epub 2010 Jun 2.
10
Dissecting variability in responses to cancer chemotherapy through systems pharmacology.
Clin Pharmacol Ther. 2010 Jul;88(1):34-8. doi: 10.1038/clpt.2010.96. Epub 2010 Jun 2.
Zotero 插件